Bid guide

How to bid on Naloxone 4mg Nasal Spray for NJ Department of Human Services

Division of Purchase and Property Trenton, NJCloses October 27, 2026

What the agency is buying

The New Jersey Department of Human Services is seeking pricing for FDA-approved naloxone 4mg nasal spray. This is an opportunity for vendors to supply a critical healthcare product to the state.

The solicitation number is 26DPP01283.

Key dates and deadlines

This solicitation was published on August 19, 2026. The deadline for submissions is October 27, 2026, at 2:00 PM ET. All responses must be submitted before this time.

Late submissions may not be considered, so it is important to plan accordingly.

Who this opportunity suits

This opportunity is suitable for businesses that supply healthcare products, specifically pharmaceutical distributors or manufacturers capable of providing FDA-approved naloxone 4mg nasal spray.

Firms with experience in government contracting or those looking to enter the public healthcare supply sector in New Jersey would find this relevant.

How to respond

To access the full bid documents, you can view the original source link provided. This will open the bid's detail page on the NJSTART procurement portal, where documents are publicly listed.

Bidders must submit their pricing using the State-Supplied Price Sheet found on the "Attachments" tab of the solicitation. Refer to Section 3.36 State-Supplied Price Sheet Instructions for details.

To submit a quote electronically, you will need to register a free vendor account on the NJSTART portal. Alternatively, follow the specific submission directions provided within the bid documents if you do not wish to submit electronically. The point of contact for questions is Donald Warren at [email protected].

Tips for a competitive response

Carefully review all sections of the solicitation, especially the State-Supplied Price Sheet Instructions, to ensure your pricing is submitted correctly. Errors in using the required format can lead to disqualification.

Ensure that the naloxone product you propose is indeed FDA-approved and meets all specified requirements. Any deviation from product specifications could render your bid non-compliant.

Submit your response well in advance of the October 27, 2026, 2:00 PM ET deadline. Technical issues can arise, and early submission provides a buffer to resolve them.

See the live bid — deadline, agency details, and how to respond

Dates and requirements can change via addenda; always verify on the bid page and at the original source before responding.

View this bid on BiddingSimple

This guide was prepared by BiddingSimple from the solicitation’s public posting. It is not official guidance from Division of Purchase and Property; the original posting controls.